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Abstract 
Diagnosis of neonatal septicemia may be difficult as the early signs of sepsis may be subtle and different at different 
gestational ages. Platelet indices are helpful in the diagnosis as well as follow-up of sepsis including assessing the 
response of antimicrobial treatment if interpreted cautiously. However, these platelet indices are not appropriate 
always. The important platelet indices available for clinical utility include mean platelet volume (MPV), platelet 
distribution width and plateletcrit that are related to morphology and proliferation kinetics of platelets. 
Thrombocytopenia is a common hematological abnormality in neonates with sepsis. Abnormal MPV can aid 
diagnosing the cause of thrombocytopenia. Low MPV associated with thrombocytopenia has been found to result in 
clinical bleeding. Until recently, the mechanism of neonatal thrombocytopenias are unclear. As a result, 
classifications based on mechanism have proved of little practical help to neonatal paediatricians because of 
overemphasis of rare conditions of known mechanism. The studies addressing the importance of these platelet 
indices and thrombocytopenia may provide insights for the early diagnosis of neonatal sepsis and therapy that would 
reduce the mortality rate. This review presents the details about the thrombocytopenia and its mechanism as a 
diagnostic measure for neonatal sepsis. 
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Introduction 
 
The neonatal period is most susceptible for infection 
than any other period of life due to exposure to a large 
number of organisms and weak neonatal host defences 
system against micro-organisms from blood and 
tissues[1]. The systemic response to infection in the 
newborn infant is called as Neonatal Sepsis. This is 
commonest cause of the mortality in infants[2]. The 
definition of early onset sepsis (EOS) is variable from 
<3 days (American Academy of Pediatrics [AAP] 
definition) to <7 days (Centers for Disease Control and 
Prevention [CDC] definition based on epidemiology  
____________ 
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studies)[3]. The incidence of neonatal sepsis in India 
was 30/1,000, as per the Neonatal Perinatal Database 
(NNPD)[4]. Fatal septicemia may occur with little 
warning and hence the timely diagnosis of sepsis in 
neonates is critical as the illness can be rapidly 
progressive and in some instances fatal.  Sepsis should 
not be regarded as a homogenous entity, as it neglects 
the pathogenic and clinical differences between the 
various causative micro-organisms and clinical 
syndromes and presentations of neonatal sepsis. Clinical 
features of sepsis are nonspecific in neonates and hence 
Early diagnosis of neonatal septicemia is a vexing 
problem[5]. Although blood culture is the “Gold 
Standard” for the diagnosis of sepsis, reports are 
available after 48-72 hours and they may be affected by 
intrapartum antibiotic administration to the mother.  
Therefore, a complete blood cell count with differential 
count is widely used, either singly or in conjunction 
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with other tests or clinical findings as a diagnostic tool 
for neonatal sepsis. Haematologic values at birth 
encompass broader ranges of normal than at any other 
time in life due to the dynamic nature of the 
developmental processes that precede and follow 
birth[6]. 
Diagnosis challenges 
Neonatal sepsis presents a diagnostic challenge to the 
neonatologists due to non-specific clinical features and 
a lack of objective evaluation. It may mimic 
noninfective conditions, such as inborn error of 
metabolism, birth asphyxia, and even respiratory 
distress syndrome in preterms. Nonetheless, over-
diagnosis and initiating unwanted empirical antibiotics 
may pose the threat of drug resistance, increasing the 
hospital stay and cost of treatment. Even with diagnosis 
with sophisticated biomarkers curtail sepsis mortality 
by timely intervention is challenging[7]. Early diagnosis 
may reduce antibiotic abuse and help in rationalising a 
unit policy for the rationale use of antibiotics. The 
current gold standard microbiological blood culture 
screen many produce false-negatives because of low 
yield when a lesser amount of blood is collected, in 
addition to high turnover time[8].  Additional 
haematological tests used traditionally, such as white 
blood cell count (WBC), absolute neutrophil count 
(ANC), immature to total neutrophil (I/T) ratio, and C-
reactive protein (CRP) measurement, also have a poor 
sensitivity and specificity and may need serial 
monitoring[9]. For better prediction of sepsis, recent 
evidence suggests the use of age-specific nomograms 
rather than fixed normal ranges of WBC, ANC, and I/T 
ratio[10]. Thus, diagnostic tests that are rapid and 
accurate in guiding the management of septic newborns 
are needed. 
Haematological Indices 
Traditionally, the following parameters (Table 1) have 
been used as the initial markers of neonatal sepsis, 
either individually or in combination: 
 
Table 1: Traditional markers for the diagnosis of Neonatal Sepsis 
Markers Features Disadvantages Ref 
Total leukocyte count 
(TLC). 
Since, few reserves of white blood cells in the neonatal bone 
marrow remaines, leukopenia can represent an overwhelming 
infection. Neutrophil indices are more reliable if obtained 
after 6–12 hours, thus delaying the diagnosis. 
Poor predictive 
value in EOS 
24,25 
Absolute Neutrophil 
Count 
In neonates this is varying from <1,800/µL at birth to 
<7,800/µL at 12–14 hours of age, and falling again to 
<1,800/µL at 72 hours. 
  
  
Immature to Total 
Leukocyte Ratio 
(I/T) ratio  
I/T ratio is calculated as ‘immature polymorphs/mature plus 
immature neutrophils’ and is the most sensitive indicator of 
sepsis. Values >0.27 in term and >0.22 in preterm neonates 
are significant. 
Less specific 
  
Platelet count 
Thrombocytopenia has been seen quite often in sepsis, 
especially fungal sepsis. Increased mean platelet volume 
(>8.6 fL) has been studied recently as a marker of EOS and a 
predictor for mortality, especially in preterm neonates 
Low positive 
predictive value 
  
 
Platelet indices and Clinical Utility 
The platelet indices have gained more importance in the 
recent studies. Among many platelet indices, the indices 
related to morphology and platelet kinetics such as 
mean platelet volume (MPV), platelet volume 
distribution width (PDW) and plateletcrit (PCT) are 
studied in sepsis. The other indices include mean 
platelet component, mean platelet mass, platelet 
component distribution width, platelet large cell ratio 
(P-LCR) and immature platelet fraction (IPF).These 
indices are related to morphology and proliferation 
kinetics of platelets and hence have a definite clinical 
utility in patients with sepsis. Platelet indices are 
biomarkers of platelet activation. These indices are of 
diagnostic and prognostic value without any added costs 
in a variety of settings including sepsis. The role of 
platelet indices in sepsis has been reported in adult 
studies. Such studies reported their role in the diagnosis 
of different grades of sepsis[11,12]. In addition, these 
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indices have been found to be useful in the prognosis of 
adverse clinical outcomes including mortality[13]. 
MPV 
The MPV is the arithmetic mean volume of the platelets 
derived from the platelet histogram and most studied 
platelet index in neonatal sepsis expressed in femtoliters 
(fL). The average MPV is 7.2–11.7 fL in healthy human 
subjects. Continuous monitoring of MPV and 
identifying the change in MPV 72 h is Usefulness in 
reducing mortality risk in patients with severe sepsis 
and/or septic shock[13]. An increased proportion of 
young platelets may result in increased MPV. Young 
platelets that are bigger and more active enter the 
circulation and hence MPV levels increase. Increased 
MPV indicates increased platelet diameter. Therefore, 
increased MPV is useful clinically as a marker of 
production rate and platelet activation. During 
conditions of rapid platelet turnover, increased MPV 
signifies the release of larger, younger platelets into the 
circulation. Neonatal sepsis showed a significant 
increase in MPV from baseline values[14] such as in 
coagulase negative Staphylococcus sepsis 
infection[15].MPVs are rather constant from 22 to 42 
wk of gestation with a slight but statistically significant 
decrease between the earlier vs later gestations[16].  It is 
important to understand the pathophysiology of 
alterations in PV and its inverse relationship with 
platelet count for the successful clinical application[17]. 
PDW-This is an indicator of volume variability in 
platelets size and reflects the heterogeneity in platelet 
morphology[18].  It increases when there is platelet 
anisocytosis. The PDW reference intervals range from 
8.3% to 56.6%. Under physiological conditions, there is 
a direct relationship between MPV and PDW; both 
usually change in the same direction. PDW changes in 
neonatal sepsis and reported 72.1% increase in the 
PDW during neonates with sepsis[19]. Perreported 
higher levels of PDW along with higher MPV during 
sepsis episodes on consecutive days among non-
survivors[20]. 
PCT 
It is the volume occupied by platelets in the blood as a 
percentage and calculated according to the formula, 
PCT = platelet count × MPV/10000. Under 
physiological conditions, the number of platelets in the 
blood is maintained in an equilibrium state by 
regeneration and elimination. The normal range for PCT 
is 0.22%-0.24%. Of the several platelet indices PCT is 
studied less often in neonatal sepsis. The variation in 
MPV affects PCT. There is a significant overlap of PCT 
between thrombocytopenic patients and patients with 
normal platelet counts. Role of platelet mass in 
predicting the occurrence of intracranial hemorrhage in 
neonates with sepsis has been reported[21]. 
Thrombocytopenia 
Neonatal sepsis is often accompanied by 
thrombocytopenia defined as Thrombocytopenia, 
defined as a platelet count below 150x109/L and late 
onset sepsis remains an important cause of 
thrombocytopenia in neonates[14,15,22].  
Thrombocytopenia affects 18–35% of all patients 
admitted to the Neonatal Intensive Care Unit. Recently, 
there has been wide interest in thrombocytopenia and 
especially the correlation between platelet count and 
clinically significant bleeding. The importance of the 
relationship between thrombocytopenia and sepsis was 
emphasized by identifying thrombocytopenia as one 
ofthe most predictive, independent risk factors for 
sepsis-associated mortality in very low-birth weight 
neonates[23]. This deserves further clarification of the 
diagnostic and prognostic meaning of thrombocytopenia 
in sepsis. Different congenital and inherited 
thrombocytopenias can be present in the fetus or 
neonate as follows[24] 
 Thrombocytopenia (with abnormal platelet function) 
Bernard-Soulier syndrome, Wiskott-Aldrich 
syndrome, X-linked thrombocytopenia, Chediak-
Higashi syndrome, Quebec platelet disorder 
Some giant platelet syndromes (e.g. Montreal 
syndrome) 
 Thrombocytopenia(without marked thrombo-
cytopathy)  
Fanconi’s anaemia, TAR syndrome, Amegakaryocytic 
thrombocytopenia 
Giant platelet syndromes (e.g. May-Hegglin anomaly, 
Sebastian syndrome, Fechtner syndrome) 
Autosomal dominant thrombocytopenia 
Mechanism of thrombocytopenia in Neonatal sepsis 
A combination of increased destruction and inadequate 
production of platelets during sepsis-induced 
thrombocytopenia of the neonate may result in release 
of young platelets into the circulation. One of the major 
sources of thrombocytopenia in neonates is sepsis and 
thrombocytopenia may quickly become very severe 
with the lowest platelet count reached within 24–48 
hours after onset of infection[25]. In neonatal sepsis, 
endothelial damage activates reticule-endothelial 
removal of platelets and this fall in platelet production 
cause thrombocytopenia, with a causative role for serum 
thrombopoietin levels[26]. Different pathological 
mechanism that cause thrombocytopenia in sepsis are 
highlighted in the figure 1.  
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Fig 1:Thrombocytopenia in sepsis 
 
Impaired platelet production 
The major mechanism underlying neonatal 
thrombocytopenia is impaired platelet production. In 
75% of all cases, the low platelet count is either present 
at birth or develops by 72 hours of life[27]. Most of the 
remaining patients are preterm neonates born after 
pregnancies complicated by placental insufficiency 
and/or fetal hypoxia—for example, maternal pre-
eclampsia and fetal intrauterine growth restriction. 
Neonates with this early onset thrombocytopenia have 
impaired megakaryocytopoiesis and platelet production; 
megakaryocytes and their precursor and progenitor cells 
are considerably reduced at birth, and levels of the 
megakaryocytopoietic cytokine thrombopoietin (Tpo) 
are therefore elevated[28,29]. 
Consumption and sequestration 
Increased platelet consumption and/or sequestration 
are the major mechanisms in about 25–35% of 
episodes of neonatal thrombocytopenia. Overall, 15–
20% of neonatal thrombocytopenias present at birth 
result from transplacental passage of maternal platelet 
alloantibodies and autoantibodies, [30] and 
disseminated intravascular coagulation is responsible 
for a further 10–15% of cases, nearly always in babies 
who are very ill, particularly in association with 
perinatal asphyxia and infection[27].  
Thrombosis or platelet activation/ immobilisation at 
sites of inflammation are further examples of neonatal 
thrombocytopenias principally caused by platelet 
consumption. In addition, there is evidence that limited 
splenic sequestration of platelets occurs in sick 
newborns[31]. 
Combined mechanisms 
A preterm neonate from a mother with pre-eclampsia 
who develops early bacterial sepsis and a baby with 
intrauterine growth restriction who develops NEC may 
both become thrombocytopenic as a result of 
underlying impaired platelet production (after pre-
eclampsia or intrauterine growth restriction) combined 
with platelet consumption (during sepsis or NEC). 
Indeed it is likely that most neonates who develop 
thrombocytopenia do so because their adverse fetal 
environment causes impaired megakaryocytopoiesis at 
birth, with a predisposition for thrombocytopenia to 
worsen when the baby is exposed to concurrent 
neonatal platelet consumptive “stress”. In addition, 
during sepsis and NEC, the natural history of 
thrombocytopenia (rapid onset and progression 
followed by slow recovery over five to seven days) 
suggests that it probably results from a combination of 
mechanisms—that is, platelet consumption (rapid onset 
phase) followed by impaired platelet production (slow 
recovery phase). 
 
 
International Journal of Health and Clinical Research, 2020;3(6):186-191                e-ISSN: 2590-3241, p-ISSN: 2590-325X                         
                                                             
____________________________________________________________________________________________________________________________________________  
____________________________________________________________________________________________________________________________________________ 
Dixit and Jain              International Journal of Health and Clinical Research, 2020;3(6):186-191 
www.ijhcr.com   
  
                         
                    190 
  
Perspective and Conclusion 
Sepsis in neonates often results in thrombocytopenia 
and changes in platelet indices. It is widely observed 
neonatal sepsis, develops thrombocytopenia (~50% 
cases) and severe thrombocytopenia (~20% cases). This 
may independent of the maternal hypertension, the 
Gram negative sepsis and intravascular thrombosis. 
Severe thrombocytopenia usually associated with major 
hemorrhages and mortality. Mortality is commonly seen 
in both thrombocytopenia and Gram negative sepsis. 
The investigation son the exact pathogenesis of 
thrombocytopenia warrants further research to stratify 
exact bacteria underlying the cause. Neonatal studies 
backing their clinical application but limitations should 
be kept in mind while interpreting results. 
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